The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI
PLOS One · 20.03.2026 · 21 (3) · e0345466
DOI: 10.1371/journal.pone.0345466 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.03.2026. Verfasst von Jingyan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients suffering from ST-segment elevation myocardial infarction (STEMI) and type 2 diabetes mellitus (T2DM) face an elevated risk of the no-reflow phenomenon even after successful primary percutaneous coronary intervention (PPCI). This study aimed to develop an integrated predictive model combining the triglyceride-glucose (TyG) index and the neutrophil-to-lymphocyte ratio (NLR) for no-reflow in this high-risk population.
Methods
A retrospective cohort of 524 patients with T2DM and STEMI undergoing PPCI was analyzed. No-reflow was defined as post-procedural TIMI flow grade ≤2. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were employed.
Results
The incidence of no-reflow was 8.97% (47/524). Both TyG index (adjusted odds ratio [aOR] 2.98) and NLR (aOR 1.23) were identified as independent predictors. Patients were stratified into four groups based on the optimal cut-offs for NLR (2.831) and TyG (9.347). The group with high levels of both markers had a substantially higher no-reflow incidence (23.21%) compared to the low-risk group (1.49%). The combined model (TyG + NLR) demonstrated superior predictive performance (AUC 0.785) over models containing either marker alone or baseline clinical factors.
Conclusion
The combination of TyG index and NLR effectively stratifies the risk of no-reflow in T2DM-STEMI patients, potentially aiding the early identification of patients in need of targeted management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Cardiology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Shandong Blood Center, Jinan, Shandong Province, China.
- The Second Clinical School, Shandong University, Jinan, Shandong, China.
ORCID-Profile: Juan Zhang
Zitieren
APA
Yang, J., Xu, D., Liu, X., Zhao, Z., & Zhang, J. (2026). The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. PLOS One, 21(3), e0345466. https://doi.org/10.1371/journal.pone.0345466
Vancouver
Yang J, Xu D, Liu X, Zhao Z, Zhang J. The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI. PLOS One. 2026;21(3):e0345466. doi:10.1371/journal.pone.0345466
BibTeX
@article{Yang2026,
author = {Yang, Jingyan and Xu, Dongling and Liu, Xiaobo and Zhao, Zixiong and Zhang, Juan},
title = {The triglyceride-glucose index and neutrophil-to-lymphocyte ratio jointly predict the no-reflow phenomenon in T2DM patients with STEMI after primary PCI},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0345466},
doi = {10.1371/journal.pone.0345466}
}
EUVIMED